Efficacy and safety of Denosumab and Zoledronic Acid in postmenospausal women with osteoporosis

Trial Profile

Efficacy and safety of Denosumab and Zoledronic Acid in postmenospausal women with osteoporosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
  • Indications Osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top